Consistent with this, we observed that TIMP3 expression in AML cell lines was very low, but increased after treatment with DAC, suggesting that this gene could be suppressed by epigenetic mechanisms such as DNA methylation. This evidence concerns the gene TIMP3 and acute myeloid leukemia.